O Lisy

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Renal actions of synthetic dendroaspis natriuretic peptide
    O Lisy
    Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Department of Physiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Kidney Int 56:502-8. 1999
  2. ncbi Potential future therapies: natriuretic peptides
    O Lisy
    Department of Physiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Coron Artery Dis 10:389-94. 1999
  3. ncbi Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure
    H H Chen
    Cardiorenal Research Laboratory, Division of Cardiovascular Diseases and Department of Physiology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Circulation 100:2443-8. 1999
  4. ncbi Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo
    O Lisy
    Division of Cardiovascular Diseases, Departments of Internal Medicine and Physiology, Mayo Clinic and Foundation, Rochester, MN, USA
    Circulation 102:338-43. 2000
  5. ncbi Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure
    O Lisy
    Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Departments of Physiology and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Hypertension 37:1089-94. 2001

Collaborators

Detail Information

Publications5

  1. ncbi Renal actions of synthetic dendroaspis natriuretic peptide
    O Lisy
    Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Department of Physiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Kidney Int 56:502-8. 1999
    ..Although previously named DNP, it remains unknown if DNP is natriuretic or if is it present in canine plasma, urine, and atrial myocardium...
  2. ncbi Potential future therapies: natriuretic peptides
    O Lisy
    Department of Physiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Coron Artery Dis 10:389-94. 1999
    ..Thus, diagnostic and therapeutic use of the natriuretic peptides is emerging as a new strategy to delay the natural history of progressive heart failure from its earliest phase to chronic congestive heart failure...
  3. ncbi Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure
    H H Chen
    Cardiorenal Research Laboratory, Division of Cardiovascular Diseases and Department of Physiology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Circulation 100:2443-8. 1999
    ..In contrast, severe CHF is characterized by sodium retention and coactivation of both ANP and the RAAS...
  4. ncbi Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo
    O Lisy
    Division of Cardiovascular Diseases, Departments of Internal Medicine and Physiology, Mayo Clinic and Foundation, Rochester, MN, USA
    Circulation 102:338-43. 2000
    ..CONCLUSIONS-Chronic mechanical unloading of the heart results in myocardial atrophy and lack of activation of ANP synthesis despite marked neurohumoral stimulation by the growth promoters ET and Ang II...
  5. ncbi Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure
    O Lisy
    Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Departments of Physiology and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Hypertension 37:1089-94. 2001
    ....